Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Context: A majority of women with polycystic ovary syndrome (PCOS) have metabolic abnormalities that result in an increased risk of developing type 2 diabetes and heart disease. Correlative studies have shown an association between changes in the gut microbiome and metabolic disorders. Two recent studies reported a decrease in α diversity of the gut microbiome in women with PCOS compared with healthy women. Objective: We investigated whether changes in the gut microbiome correlated with specific clinical parameters in women with PCOS compared with healthy women. We also investigated whether there were changes in the gut microbiome in women with polycystic ovarian morphology (PCOM) who lacked the other diagnostic criteria of PCOS. Participants: Subjects were recruited at the Poznan University of Medical Sciences. Fecal microbial diversity profiles of healthy women (n = 48), women with PCOM (n = 42), and women diagnosed with PCOS using the Rotterdam criteria (n = 73) were analyzed using 16S ribosomal RNA gene sequencing. Results: Lower α diversity was observed in women with PCOS compared with healthy women. Women with PCOM had a change in α diversity that was intermediate between that of the other two groups. Regression analyses showed that hyperandrogenism, total testosterone, and hirsutism were negatively correlated with α diversity. Permutational multivariate analysis of variance in UniFrac distances showed that hyperandrogenism was also correlated with β diversity. A random forest identified bacteria that discriminated between healthy women and women with PCOS. Conclusion: These results suggest that hyperandrogenism may play a critical role in altering the gut microbiome in women with PCOS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In keeping with the developmental origins hypothesis previously discussed, maternal androgens may alter the composition and function of the microbiome, therefore facilitating the pathogenesis of PCOS [140].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although most studies are small, dysbiosis has consistently been found to correlate with different physiological parameters, such as obesity, sex hormones and metabolic defects [140,141,143].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One study showed that beta diversity, which is used to measure differences between groups, was negatively correlated with hyperandrogenism, suggesting that androgens play a significant role in dysbiosis [140].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Decreased α-diversity has been described in women with PCOS [109, 110].”
From Polycystic Ovary Syndrome: Pathophysiology, Presentation, and Treatment With Emphasis on Adolescent Girls (2019) · cites this paper as [110]
The cited source says what the claim attributes to it.
In the citing paper
“Dysbiosis is a consistent finding when looking at the microbiome of women with PCOS [140,141,142,143].”
From Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment (2022) · cites this paper as [140]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb01338.x · Cited by 88,486
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb00917.x · Cited by 48,949
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209 · cited 1×
“The resulting SVs were then aligned using MAFFT (21), and a phylogenetic tree was built using FastTree (22).”
MethodDADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · cited 1×
“DADA2 software was used to obtain a set of observed sequence variants (SVs) (19).”
MethodQIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887 · cited 1×
“6/) (18) using the q2-tools-import script, and sequences were demultiplexed using the q2-demux emp-single script.”
MethodSelf-citationAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“Fecal microbiome transplantation from obese humans into germ-free mice also resulted in an obese phenotype, indicating a potential causative role of the gut microbiome in the development of metabolic disorders (13, 14).”
BackgroundUltra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839 · cited 1×
“For each sample, the V4 hypervariable region of the 16S ribosomal RNA (rRNA) gene was polymerase chain reaction (PCR) amplified with primers 515F and 806R (16).”
MethodHuman gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Cited by
Items 201–300 of 414
Kusamoto, A., Harada, M., Azhary, J. M. K., Kunitomi, C., Nose, E., Koike, H., Xu, Z., Urata, Y., Kaku, T., Takahashi, N., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101051r · Cited by 19
Ibuprofen Reduces Testosterone Level in Women With Polycystic Ovary Syndrome
Banaszewska, B., Ożegowska, K., Polska, M., Pawelczyk, L. A., Chang, R. J., & Dulęba, A. J. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac128 · Cited by 17
“Our recent studies have revealed that women with PCOS have elevated serum markers of endotoxemia: lipopolysaccharides (LPS) and LPS-binding protein [11], possibly due to increased gut wall permeability and/or altered gut microbiome [12].”
BackgroundSelf-citationLi, X., Jiang, B., Gao, T., Nian, Y., Bai, X., Zhong, J., Qin, L., Gao, Z., Wang, H., & Ma, X. (2024) · European journal of medical research · doi:10.1186/s40001-024-02034-9 · Cited by 19
The role of reproductive tract microbiota in gynecological health and diseases
Wang, Z., Zhang, L., Liu, X., & Xu, L. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104418 · Cited by 18
Sex hormones–Gut microbiome axis: An update of what is known so far
Zommiti, M., & Feuilloley, M. G. J. (2025) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2025.100571 · Cited by 17
Dou, P., Zhang, T.-T., Xu, Y., Xue, Q., Zhang, Y., Shang, J., & Yang, X.-L. (2024) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303286777240223074922 · Cited by 15
Zhu, S., Chen, H., He, B., Zhang, Y., Li, P., & Kuang, J. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1659783 · Cited by 15
Sun, Z., Yu, S., Tian, Y., Han, B., Zhao, Y. M., Li, Y., Wang, Y., Sun, Y., & Shen, W. (2022) · Food & Function · doi:10.1039/d1fo03145g · Cited by 15
Geng, Y., Liu, Z., Hu, R., Ma, W., Wu, X., Dong, H., Song, K., Xu, X., Huang, Y., Li, F., et al. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01236-9 · Cited by 16
“Several leading studies have highlighted a reduction of α diversity and an alteration of β diversity, the former of which is a causal factor for obesity [57, 58, 106, 107].”
BackgroundChudzicka-Strugała, I., Gołębiewska, I., Banaszewska, B., Trzcinski, M., Brudecki, G. P., Elamin, W. F., & Zwoździak, B. (2024) · Diagnostics · doi:10.3390/diagnostics14040404 · Cited by 19
“Moreover, androgens have been shown to modulate the gut microbiome, which is associated with intestinal dysbiosis in women with PCOS and hyperandrogenism [49,56,57].”
BackgroundSelf-citationKushawaha, B., Rem, T. T., & Pelosi, E. (2025) · Biomolecules · doi:10.3390/biom15060834 · Cited by 15
Chen, X., Wan, Y., & Xie, L. (2025) · Biology of Reproduction · doi:10.1093/biolre/ioaf197 · Cited by 23
The emerging role of the gut microbiome in polycystic ovary syndrome
He, Y., Jin, X., Wang, H., Dai, H., Lu, X., Zhao, J., Zhang, H., Chen, W., & Wang, G. (2021) · F&S Reviews · doi:10.1016/j.xfnr.2021.03.003 · Cited by 16
Sharma, U., Sahu, A., Thakur, N., Choudhary, R. K., Shekhar, H., Haque, S., Tuli, H. S., Aubakirova, A. T., & Sharma, B. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05409-6 · Cited by 15
The modern pathogenetic challenges of polycystic ovary syndrome
Pakharenko, L. V., Zhylka, N. Y., Shcherbinska, O. S., Kravchuk, I. V., Lasytchuk, O. M., Zhurakіvskyi, V. M., & Kaminskyi, V. (2024) · Reproductive health of woman · doi:10.30841/2708-8731.2.2024.304662 · Cited by 15
Li, J., Liu, D., Zhao, H., Zhang, P., Cai, F., Li, H., & Chu, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112491 · Cited by 15
Parua, S., Hazra, A., Adhikary, K., Ganguly, K., Ahuja, D., Maiti, R., Mukhopadhyay, L. D., Dutta, S., Panda, P., Bhattacharya, K., et al. (2025) · Obesity Medicine · doi:10.1016/j.obmed.2025.100626 · Cited by 15
Chan, S., Barton, S. J., Loy, S. L., Chang, H., Titcombe, P., Wong, J.-T., Ebreo, M., Ong, J., Tan, K. M. L., Nield, H., et al. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.01.047 · Cited by 16
Gut microbiota and ovarian diseases: a new therapeutic perspective
Ju, S., Kang, Z., Yang, L., Xia, Y., Guo, Y. M., Li, S., Yan, H., Mao, Q., Wang, H. P., & Zhong, L. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01684-5 · Cited by 13
“On the other hand, beta diversity significantly affects bowel function, insulin levels, glucose tolerance, and androgen levels [45], all of which can worsen the symptoms of PCOS [46–47].”
Wu, D., Xia, M., Yan, A., Jiang, H., Fan, J., Zhou, S., Wei, X., Liu, S., & Chen, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-38577-w · Cited by 13
Han, T. L., Liu, S., Liu, H., Wang, X., Yang, X., Chan, S., Tumanov, S., Cannon, R. D., Yang, Y., & Han, T.-L. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05099-7 · Cited by 14
“Other studies reported that a decrease in α diversity was negatively correlated with total testosterone levels and hirsutism in PCOS patients [15] and that both α diversity and β diversity were reduced in a letrozole-induced PCOS mouse models [16].”
Sudhakaran, G., Sreekutty, A. R., Choi, K. C., Arasu, M. V., Guru, A., Namasivayam, S. K. R., & Arockiaraj, J. (2026) · Current Microbiology · doi:10.1007/s00284-026-04749-w · Cited by 11
“Research has shown that PCOS women have an unbalanced gut microbiota similar to that of obese non-PCOS women, suggesting a confusing link between the two [ 27, 48 , 55, 56].”
Łagowska, K., Malinowska, A. M., Kapczuk, K., Mikołajczyk-Stecyna, J., Chmurzyńska, A., & SCHMIDT, M. T. (2022) · Nutrition · doi:10.1016/j.nut.2022.111606 · Cited by 11
Lindheim, L., Manti, M., Fornes, R., Bashir, M., Czarnewski, P., Diaz, O. E., Seifert, M., Engstrand, L. G., Villablanca, E. J., Obermayer-Pietsch, B. M., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00266 · Cited by 13
“Two subsequent studies by independent research groups have yielded similar results [13, 14].”
ResultSau, L., Olmstead, C., Cui, L. J., Chen, A., Shah, R. S., Kelley, S. T., & Thackray, V. G. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa173 · Cited by 13
Self-citationEspinosa, M. E., Angélica Melo, A., León, M., Bautista-Valarezo, E., Zambrano, F., Uribe, P., Bravo, A., Taubert, A., Hermosilla, C. R., Iturrieta, V., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13082278 · Cited by 10
“The effect of sex steroid hormones as well as the intestinal microbiome have been extensively investigated [13–15], but inflammatory states and the vaginal microbiota require further evaluation [16,17].”
BackgroundGut microbiome dysbiosis in PCOS: from pathogenesis to microbiome-targeted therapies
Du, X., Su, H., Huang, Y., Liu, J., Li, Q., Yang, X., Tao, X., & Li, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1747766 · Cited by 12
Vaginal microbiome in patients with menstrual cycle disorders (review)
Op, L., Грязнова, М. В., Kozarenko, O. N., Сыромятников, М. Ю., & Popov, V. N. (2021) · RESEARCH RESULTS IN BIOMEDICINE · doi:10.18413/2658-6533-2021-7-4-0-9 · Cited by 10
“У женщин c СПКЯ хорошо описаны особенности микробиома ротовой полости и кишечника [74-79].”
Lee, Y. Z., Cheng, S.-H., Lin, Y., Wu, C.-C., & Tsai, Y.-C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168706 · Cited by 11
Yang, J., Wang, E., Jiang, M., Tan, Y., Yao, F., Sun, C., Pan, L., Gao, L., & Yao, J. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01193-3 · Cited by 11
“For example, compared with healthy women, PCOS patients had lower α diversity of the GM, which correlated with the increase in androgens [12].”
ResultPolycystic Ovarian Syndrome: A Review of Multi-omics Analyses
Naqvi, I., Bandyopadhyay, A., Panda, A., & Hareramadas, B. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-01789-8 · Cited by 11
“…androgens by the gut microbial enzymes, resultant release of lipo-metabolites of testosterone and gonadal & adrenal androgens, and subsequent activation of androgen receptors in women, as well as modulation of immune responses via cytokine-mediated (e.g., IL-22) pathway [156, 170, 177, 178, 183].”
From gut to gamete: how the microbiome influences fertility and preconception health
Munyoki, S. K., Vukmer, N. A., Rios, J. M., Kallen, A. N., & Jašarević, E. (2025) · Microbiome · doi:10.1186/s40168-025-02230-7 · Cited by 11
“…signatures characterize women with reproductive disorders, including primary ovarian insufficiency (POI) [52], polycystic ovarian syndrome (PCOS) [53, 54], decreased ovarian reserve [55], endometriosis [56], and early menopause [57, 58], who exhibit alterations in gut microbiota composition and…”
Research progress of gut microbiota and its metabolites in polycystic ovary syndrome
Qin, S., Guo, S., Tan, X., Li, K., & Huang, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1700191 · Cited by 10
Youngblut, N. D., de la Cuesta‐Zuluaga, J., & Ley, R. E. (2022) · Environmental Microbiology · doi:10.1111/1462-2920.15910 · Cited by 12
Metabolic dysregulation and gut dysbiosis linked to hyperandrogenism in female mice
Chen, A., Handzel, A. A., Sau, L., Cui, L. J., Kelley, S. T., & Thackray, V. G. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.443 · Cited by 10
Self-citationShah, R. D. (2019) · Children · doi:10.3390/children6080089 · Cited by 9
“Human studies similarly found lower alpha diversity in PCOS with both alpha and beta diversity correlated to markers of hyperandrogenism [70,71].”
BackgroundFan, H., Hong, X., Zeng, J., Wang, X., & Chen, J. (2021) · Trials · doi:10.1186/s13063-021-05426-y · Cited by 9
Huang, L., Xu, L., Yun, C., Qiao, J., & Qi, X. (2025) · Life Medicine · doi:10.1093/lifemedi/lnaf029 · Cited by 9
“In patients meeting the Rotterdam criteria, PCOS is associated with diminished α diversity and distinct β diversity patterns, particularly those marked by overgrowth of Bacteroides vul-gatus , which is a putative driver of microbial imbalance [59].”
Bile acids and gut microbiota: interactions and impacts on polycystic ovary syndrome
Qian, H., Tao, J., Shi, L., Haiyan, S., Yang, L., Cui, L. J., Xu, W., & Wang, L. (2026) · Frontiers in Microbiomes · doi:10.3389/frmbi.2025.1702198 · Cited by 8
Zheng, S., Chen, H., Yang, H., Zheng, X., Fu, T., Qiu, X., & Wang, M. (2024) · Frontiers in Microbiomes · doi:10.3389/frmbi.2023.1229723 · Cited by 8
Beyond the reproductive tract: gut microbiome and its influence on gynecological health
Pérez‐Prieto, I., Rodríguez-Santisteban, A., & Altmäe, S. (2024) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/gco.0000000000000952 · Cited by 9
Polycystic ovary syndrome: new and promising treatment methods
Муратовна, Г. Д., Sheremetyeva, E. V., Kalashnikova, M. F., Dzgoeva, F. K., & Алборова, Е. Т. (2024) · Problems of Endocrinology · doi:10.14341/probl13400 · Cited by 13
Fernanda, T., Kelley, S. T., DeMasi, T., Giltvedt, K., Tsang, M., Nannini, K., Kern, M., & Hooshmand, S. (2025) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001987 · Cited by 8
“Moreover, the link between Faecalibacterium and hormonal imbalance conditions, such as polycystic ovary syndrome (PCOS), could highlight its potential relevance in our findings, with prior research identifying Faecalibacterium prausnitzii as a distinguishing taxon in women with PCOS [17].”
Self-citationPolycystic ovary syndrome and nonalcoholic fatty liver disease
Georgescu, C. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00007-9 · Cited by 10
Wydra, J., Szlendak-Sauer, K., Zgliczyńska, M., Żeber‐Lubecka, N., & Ciebiera, M. (2024) · Nutrients · doi:10.3390/nu16193382 · Cited by 8
“This is consistent with the previous study in which letrozole-induced PCOS resulted in the greater relative abundance of Ruminococcaceae genus in pubertal female mice [43].”
BackgroundResultLinking altered gut microbiome to polycystic ovarian syndrome through immune mediated pathway
Pathak, V. A., Kshirsagar, S. J., & Deokar, G. S. (2025) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2025.104648 · Cited by 8
The dynamic relationship of gut microbiota with sex hormones in systemic lupus erythematosus
Katrib, M., Haddad, R., Hamdan, Z., & Rida, M. A. (2023) · Reumatologia/Rheumatology · doi:10.5114/reum/163091 · Cited by 8
“In addition, a negative association was found between diversity (PD and richness indexes) and testosterone levels when combining women with PCOS and healthy women [25].”
BackgroundAlessandri, G., Mancabelli, L., Fontana, F., Lepore, E., Forte, G., Burratti, M., Ventura, M., & Turroni, F. (2024) · Microbial Biotechnology · doi:10.1111/1751-7915.14540 · Cited by 7
An overview of the physiopathology and various treatment strategies for polycystic ovary syndrome
Rajabi, A., Babaie, S., Oskouei, B. S., Mehdizadeh, A., & Farshbaf‐Khalili, A. (2023) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000088 · Cited by 7
Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
Dzienny, A. C., & Seifer, D. B. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15110518 · Cited by 7
“Individuals with PCOS have also been found to show a hierarchical clustering of species that can distinguish samples from healthy controls [27,28].”
Xia, X., Chen, Y., Zhang, X., Wang, J., Xu, H.-Y., & Zhao, R. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02076-y · Cited by 6
Dai, R., & Sun, Y. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123318 · Cited by 6
Li, S., Lu, R., Zhou, B., Wan, R., Yan, Y., He, J., Wu, J., Feng, X., Yang, X., & Liang, X. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106821 · Cited by 6
Liu, Y., Han, Y., Jiang, Y., Zhang, J., & Zhang, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1531506 · Cited by 7
Polycystic Ovary Syndrome (PCOS)
Hechtman, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00209-0 · Cited by 7
Corrie, L., Singh, S. K., Gulati, M., Awasthi, A., Khursheed, R., Kaur, J., & Vishwas, S. (2022) · Current Women s Health Reviews · doi:10.2174/1573404818666220329123334 · Cited by 6
Bubnov, R. V., & NIa, S. (2018) · Preprints.org · doi:10.20944/preprints201809.0185.v1 · Cited by 6
A multi-omic study profiles women with PCOS to reveal unique gut microbiome compositions
Lili, L., Kunces, L. J., Meydan, C., Pesce, S., Afshin, E. E., Rickard, N., Stujenske, T. M., D’Adamo, C. R., Dudley, J. T., Zhang, B., et al. (2025) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbaf012 · Cited by 5
Srivastava, S., & Mohanty, B. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-02009-z · Cited by 5
“2D representation of the interactions between butyrate and TLR4/MD-2 complex ( c ), MyD88 ( f ) and NF-κB ( i ) of gut microbiota has been reported to be influenced by the estrogen level, suggesting the bi-directional communication between gut microbiota and estrogen [12 ].”
Liu, S., Wang, R., Yu, W., Shi, C., Wang, X., Liu, A., & Zhang, L. (2026) · Nutrients · doi:10.3390/nu18060964 · Cited by 6
Endometrial Receptivity in Patients with Polycystic Ovary Syndrome
Albu, A. I., & Albu, D. N. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98624 · Cited by 5
The Role of the Gut Microbiome in Youth with Polycystic Ovary Syndrome: A Systematic Review
Tsinopoulou, V. R., Kotanidou, E. P., Athanasiadis, N., Sapountzi, E., Bacopoulou, F., Ntzani, E., Galli‐Τsinopoulou, A., & Christoforidis, A. (2023) · Children · doi:10.3390/children10121872 · Cited by 5
“Differences occurred in four genes known to produce SCFAs, which were found at a lower rate in women with PCOS compared to the other examined groups [47].”
ResultKusamoto, A., Harada, M., Minemura, A., Matsumoto, A., Oka, K., Takahashi, M., Sakaguchi, N., Azhary, J. M. K., Koike, H., Xu, Z., et al. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1365624 · Cited by 5
Wang, B., Hu, L., & Dong, P. (2024) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2024.100178 · Cited by 5
“In contrast, Lindheim [18] found that PCOS patients had approximately 15 % lower Faith PD and OTU counts than the healthy group, while Torres [19] further corroborated that PCOS can lead to a reduction in gut microbiota diversity based on observed SVs ( P = 0.04) and Faith PD ( P = 0.02).”
ResultInfluentialWu, R., Mai, Z., Song, X., & Zhao, W. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1524521 · Cited by 5
Jiang, X., Wang, Y., Hua, Y., Tang, H., & Li, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1610869 · Cited by 5
PyBootNet: a python package for bootstrapping and network construction
Akhavan, S. R., & Kelley, S. T. (2025) · PeerJ · doi:10.7717/peerj.18915 · Cited by 5
Self-citationYang, X., Luo, H., Li, Q., Zhu, W., Fu, L., Chen, L., Li, X., Su, H., Zhang, L., & Huang, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202502661r · Cited by 5
From Gut to Reproductive Health: Exploring Microbiome Interactions and Future Interventions
Singh, S., Kriti, M., Sharma, P., Pal, N., Sarma, D. K., Verma, V., Tiwari, R. R., & Kumar, M. (2025) · Reproductive Sciences · doi:10.1007/s43032-025-02001-7 · Cited by 5
“Patients with PCOS have reduced SCFA-producing bacteria, leading to inflammation and gut permeability [ 99].”
Wang, Y., Shao, X., & Yang, X. (2025) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2025.106919 · Cited by 4
Kuang, J., Luo, J., He, X., Yu, T., Zhou, Y., Zhang, X., Liu, Z., & Chen, T. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.107061 · Cited by 4
Kong, F., Huang, P., Chen, J., & Ma, Y. (2024) · Reproductive Sciences · doi:10.1007/s43032-024-01562-3 · Cited by 5
“…Tenericutes ↓ Yin/2021 [26] China Homo ↓ Altered Bacteroidetes ↓ , Proteobacteria ↓ Zhou/2021 [22] China Homo ↑ Altered Bacteroides ↑ Thackray/2018 [32] UK Homo ↓ Altered Faecalibacterium prausnitzii ↑ , Ruminococcus bromii ↓ Yang/2021[22] China Homo ↓ - Parabacteroides distasonis , Escherichia…”
Zhu, W., Fu, L., Xu, C., Peng, K., Liu, Y., Tang, H., Huang, Y., & Yang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.978019 · Cited by 4
“Meanwhile, patients with PCOS have a lower diversity and an altered phylogenetic profile in the microbiome (Liu et al., 2017b; Lindheim et al., 2017; Torres et al., 2018).”
BackgroundLi, Z., Liu, Y., Wang, Y., Cai, Q., Wang, Y., Bai, Y., Liu, H., Xu, C., & Zhang, F. (2024) · Biology of Reproduction · doi:10.1093/biolre/ioae058 · Cited by 3
“The role of gut microbiota and its metabolites in its pathogenic process has also been verified in the study of patients and model mice [10–12].”
Zhang, Y., Chen, M., Zhou, Z. G., Guo, Y., Zheng, L., Yu, Y., Liu, J., Zhou, Y., Lu, H., Yao, S., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1517934 · Cited by 3
Yang, W., Yin, L., Xie, Q., Tan, M., Liu, Y., Xu, J., & Wu, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1699600 · Cited by 3
Khade, K., Dadachanji, R., Bhonde, G., Patil, A. D., Bhor, V. M., & Mukherjee, S. (2026) · Future Microbiology · doi:10.1080/17460913.2026.2634572 · Cited by 3
Unraveling the mechanisms of PCOS: the interplay between gut microbiota and the immune system
Liu, J., Wang, L., Jiang, M., Yan, H., Zhang, G., Li, N., Zhao, Y., Du, X., Zeng, Q., Xiong, D., et al. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02047-4 · Cited by 4
“Moreover, in PCOS patients, variations in the gut microbiome’s genomic structure (SVs) and phylogenetic diversity are negatively correlated with testosterone levels and symptoms of hir-sutism [38].”
Zhou, M., Luo, Y., Qiu, J., Wang, H., Li, X., Zhang, K., Li, X., Yaqoob, M. U., & Wang, M. (2025) · Poultry Science · doi:10.1016/j.psj.2024.104755 · Cited by 3
Huang, X., Wu, L., Zhang, Y., Lai, X., & Sun, D. (2025) · Endocrine Connections · doi:10.1530/ec-25-0162 · Cited by 3
“The results indicated that hyperandrogenemia might play a key role in altering the gut microbiota in women with PCOS (54).”
InfluentialMazzei, R., Patitucci, A., Magariello, A., Russo, G., & Tagarelli, G. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120730 · Cited by 3
Salivary microbiome differences in prepubertal children with and without adrenal androgen excess
Wise-Oringer, B. K., Burghard, A. C., Park, H., Auchus, R. J., Oberfield, S. E., & Uhlemann, A. (2021) · Pediatric Research · doi:10.1038/s41390-021-01661-w · Cited by 3
Gao, X., Zhao, H., Shi, Q., Zou, T., & Zhu, Y. (2024) · Medicine · doi:10.1097/md.0000000000040115 · Cited by 4
Gut Microbiome: A Potential Controller of Androgen- Modulated Disease
Yu, Q. G. C. (2021) · Online Journal of Complementary & Alternative Medicine · doi:10.33552/ojcam.2021.06.000628 · Cited by 3
Sisk-Hackworth, L., Akhavan, S. R., Krutkin, D. D., Kelley, S. T., & Thackray, V. G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.01.601610 · Cited by 3
“Understanding how this process occur is important because the gut microbiome is linked to many diseases that have a sex bias or perturbation of sex steroid levels, including inflammatory bowel syndrome [14], polycystic ovary syndrome [15], and type I diabetes [16].”
Self-citationAL-Rekabi, S. A., & Noori, N. (2023) · Journal of the Pakistan Medical Association · doi:10.47391/jpma.iq-31 · Cited by 2
Xia, D., Xu, L., Cheng, X., Li, C., Chen, S., & Zhang, Y. (2024) · African Journal of Reproductive Health · doi:10.29063/ajrh2024/v28i12.14 · Cited by 2
Wang, Y., Ding, J., Min, Y., Zhang, Y., Ming, J., & Yin, T. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70108 · Cited by 2
“64,65 The Dysbiosis of the Gut Microbiota (DOGMA) hypothesis suggests that increased intestinal permeability following an imbalance in the gut flora leads to the leakage of lipopolysaccharide (LPS) into the systemic circulation.”
Veličković, N. A., Vratarić, M., Mićić, B., Teofilović, A., Radovanović, M., Ignjatović, S., Gašić, U., Djordjevic, A. D., Μacut, D., & Milutinović, D. V. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01103-9 · Cited by 2
“Namely, it was shown that the abundance and diversity of intestinal microbiota are significantly decreased in the 5α-dihydrotestosterone (DHT)-induced PCOS animal model [65], and that gut microbiota richness and phylogenetic diversity are dramatically reduced in PCOS patients [57].”
Shetty, S., Karunakara, M. B., Kristipati, R. R., Kalthur, G., & Kumari, S. (2025) · F1000Research · doi:10.12688/f1000research.167998.1 · Cited by 2
Liang, Y., Li, S., Chen, G., Huang, Q., Yang, X., Li, X., Lu, L., Hong, Y., Lin, K., Chen, F., et al. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02107-8 · Cited by 2
“Previous studies reported reduced microbial diversity and depletion of beneficial taxa (e.g., Lactobacillus , Bifidobacterium and Prevotella ) in PCOS patients [25, 28–30].”
Russo, M., Porcaro, G., Aragona, C., Bilotta, G., Liberto, M. D., & Unfer, V. (2025) · Nutrients · doi:10.3390/nu17233695 · Cited by 2
“Furthermore, higher total testosterone levels and clinical signs of hyperandrogenism (such as hirsutism) were negatively correlated with microbial diversity, suggesting that androgens may influence the composition of the gut microbiota in women with PCOS [59].”
Patel, J., Chaudhary, H., Parekh, B., & Joshi, R. G. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02081-2 · Cited by 2
“Recent studies have identified significant differences in the composition of the gut microbiota between women with PCOS and Non-PCOS, highlighting the potential role of the gut microbiome in the pathogenesis of PCOS [13, 14].”
Gut microbiota and pattern recognition receptors in polycystic ovary syndrome
Yuan, J., Sun, S., Ibrahim, E. H., Din, M. A. U., Mao, F., & Du, S. (2026) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2026.104882 · Cited by 2
Wu, Z., Sun, X., Li, X., Wang, H., Liang, H., Wang, M., Yang, Z., Zhao, K., He, N., Xiao, L., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-10031-3 · Cited by 2
“At the beta diversity level, Principal Coordinate Analysis (PCoA) 23,24 based on Bray-Curtis 25 dissimilarity showed a clear separation in microbial community structure among the three cohorts 26 (Fig.”
Food processing-derived carbon dots disrupt male fertility via the gut-testis axis
Chen, P., My, M., Li, Y., Chen, X. S., Xu, Z., Guo, J., Hu, X., Lv, L., Guo, J., & Liu, G. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3252-6 · Cited by 3
“This bidirectional network linking the gut microbiota to male reproductive function operates through gut barrier integrity, microbial metabolite production, and inflammatory control — all of which are disrupted by nanoparticle exposure (Al-Asmakh et al., 2014; Torres et al., 2018).”
Gut microbiota in PCOS: key microbial changes, potential mechanisms and clinical applications
Shi, S., Ma, J., Jing, X., Jia, W., & Sun, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08352-2 · Cited by 2
“Studies have indicated that there exists a negative correlation between the α-diversity of the gut microbiota and the overall testosterone levels in the body, thereby demonstrating the association between the two [66].”
Simultaneous alterations in ovaries and bone as a result of Polycystic Ovary Syndrome
Bonfá, A. L. D. O., Alves, E. D., Fabrício, V., Nonaka, K. O., Anselmo-Franci, J. A., Achcar, J. A., & Montrezor, L. H. (2021) · International Journal of Advances in Medical Biotechnology - IJAMB · doi:10.25061/ijamb.v3i2.81 · Cited by 2
Polycystic ovarian syndrome and microbiome: Implications for women’s health
Patel, N., Singh, D., Lokary, V., & Shaker, I. A. (2023) · Journal of Medical and Scientific Research · doi:10.17727/jmsr.2023/11-10 · Cited by 2
Microbiota and its therapeutic implications in reproductive health and diseases
Singh, P., & Srivastava, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99336-4.00003-3 · Cited by 5
Metadata
- Authors
- Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G.
- Affiliations
- San Diego State University (US)
- Poznan University of Medical Sciences (PL)
- Department of Reproductive Medicine, University of California, San Diego, La Jolla, California
- University of California San Diego (US)
- Corresponding author
- Thackray, Varykina G
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-01-23
- Volume
- 103
- Issue
- 4
- Pages
- 1502-1511
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6276580
- OpenAlex
- W2792000617
- Cited by
- 399
- References
- 42
- Citations by year
- 2026: 49 · 2025: 61 · 2024: 69 · 2023: 55 · 2022: 44 · 2021: 57 · 2020: 37 · 2019: 20 · 2018: 5
- FWCI
- 31.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD012303, R01HD082567)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- polycystic ovary syndrome, gut microbiota, hyperandrogenism, alpha diversity, beta diversity, polycystic ovary morphology, hirsutism, total testosterone, fecal microbiota, 16S rRNA gene sequencing, type 2 diabetes risk, metabolic disorders
- MeSH terms
- Gastrointestinal Microbiome, Adult, Feces, Female, Humans, Polycystic Ovary Syndrome, RNA, Ribosomal, 16S, Hyperandrogenism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.